BackAbiomed Overview

Abiomed Current Cash

Track Abiomed's current cash ($820M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$820.37M
↑ 26.10% YoYΔ $169.81M vs prior year quarter

Peer trimmed avg / median

Loading

Abiomed Current Cash History

Loading

Abiomed vs. peers: Current Cash Comparison

Loading

Abiomed Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Abiomed (ABMD) FAQ

Abiomed (ABMD) currently reports a current cash of $820M as of September 2022. That compares with $650M in the prior-year period — up 26.1% year over year. Use the charts on this page to explore Abiomed's current cash history and peer comparisons.

Abiomed's current cash increased from $650M to $820M — a 26.1% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abiomed reported $820M in current cash as of September 2022. That compares with $650M in the prior-year period — up 26.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $820M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abiomed, and consider following ABMD for alerts when major investors trade the stock.

Abiomed is classified in the Healthcare sector. On current cash, it currently shows $820M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABMD with unrelated industries.